Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2021-09-07 Major Shareholding Noti…
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including stock option exercises and grants. This falls under the category of Major Shareholding Notification (MRQ).
2021-09-07 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회 결과' (Extraordinary General Meeting Results) and details the resolutions passed during the meeting held on 2021-09-01, including amendments to the articles of incorporation and stock option grants. Since it reports the official outcome of a shareholder meeting, it falls under the category of Declaration of Voting Results.
2021-09-01 Korean
본점소재지변경
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding a change in the company's headquarters location (본점소재지변경). It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a standard corporate regulatory disclosure that does not fall into the other specialized categories, it is classified as a general regulatory filing.
2021-09-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. In the context of Korean financial regulatory filings (DART system), this type of disclosure regarding stock option grants is classified as a general regulatory filing (RNS) as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes).
2021-09-01 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options). It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. In the context of Korean financial regulatory filings (DART system), this type of disclosure regarding stock option grants is classified as a general regulatory filing (RNS) as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes).
2021-09-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory disclosure for insider share transactions (director's dealing). In the provided taxonomy, 'Director's Dealing' (DIRS) is the correct category for reports detailing personal share transactions by company directors and executives.
2021-08-19 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.